Multivariable analysis of pre-ASCT variables for OS
OS . | |||||
---|---|---|---|---|---|
. | Term . | Univariable HR . | Univariable P value . | Multivariable HR . | Multivariable P value . |
ASC MRD-positive | |||||
Yes | 2.00 | .05 | 2.14 | .07 | |
Male | |||||
Male | 1.19 | .55 | |||
Age (60+) | |||||
Yes | 1.41 | .21 | |||
Diagnosis | |||||
PMBCL | 0.69 | .60 | |||
TIL | 1.81 | .03 | |||
Primary refractory | |||||
Yes | 0.65 | .16 | |||
Chemo lines | |||||
3-4 | 0.60 | .21 | |||
Pre-ASCT CMR | |||||
Yes | 0.84 | .53 | |||
Pre-ASCT DS of 1-3∗ | |||||
Yes | 1.09 | .85 | |||
Conditioning | |||||
CBV | 1.66 | .10 | |||
Other | 0.00 | 1.00 | |||
DHL | |||||
Yes | 2.24 | .03 | 3.88 | .01 | |
DEL | |||||
Yes | 2.59 | .002 | 3.61 | .001 |
OS . | |||||
---|---|---|---|---|---|
. | Term . | Univariable HR . | Univariable P value . | Multivariable HR . | Multivariable P value . |
ASC MRD-positive | |||||
Yes | 2.00 | .05 | 2.14 | .07 | |
Male | |||||
Male | 1.19 | .55 | |||
Age (60+) | |||||
Yes | 1.41 | .21 | |||
Diagnosis | |||||
PMBCL | 0.69 | .60 | |||
TIL | 1.81 | .03 | |||
Primary refractory | |||||
Yes | 0.65 | .16 | |||
Chemo lines | |||||
3-4 | 0.60 | .21 | |||
Pre-ASCT CMR | |||||
Yes | 0.84 | .53 | |||
Pre-ASCT DS of 1-3∗ | |||||
Yes | 1.09 | .85 | |||
Conditioning | |||||
CBV | 1.66 | .10 | |||
Other | 0.00 | 1.00 | |||
DHL | |||||
Yes | 2.24 | .03 | 3.88 | .01 | |
DEL | |||||
Yes | 2.59 | .002 | 3.61 | .001 |
A subset of patients (53/98) had PET imaging available for retrospective assessment using the Deauville scoring system.